Author: Gábor Winkler
View More View Less
  • 1 Szent János Kórház II. Belgyógyászat-Diabetológia Budapest Diós árok 1–3. 1125
  • | 2 Miskolci Egyetem, Egészségügyi Kar Elméleti Egészségtudományi Intézet Miskolc
Restricted access

Tapasztalatok szerint az inzulin bevezetése 2-es típusú diabetesben gyakran késik, jóllehet a kívánttól elmaradó anyagcserekontroll azonnali és hosszú távú következményei jól ismertek. Ez a magyarázata, hogy a korai, de legalább az időben megkezdett inzulinadás kezelési útmutatásokban mind nagyobb hangsúlyt kap. A közlemény áttekinti a betegség korai – első kezelésként alkalmazott −, illetve későbbi szakaszában indított inzulinadás lehetséges előnyeit (béta-sejt-diszfunkció mérséklése, a progresszió lassítása, tartósabb és hosszú távon kedvezőbb anyagcserekontroll), valamint potenciális korlátozó tényezőit (nem kívánt vércukoresések gyakoribb előfordulása, súlygyarapodás, romló beteg-együttműködés). Rámutat arra, hogy inzulin adása megfelelő kezelésválasztással a 2-es típusú diabetes minden szakaszában biztonságos terápiás alternatíva, jól igazítható az individuális glykaemiás célhoz és körültekintő betegoktatással nem rontja az érintettek életminőségét és nem hátráltatja hosszú távú kezelési együttműködésüket sem. Orv. Hetil., 2014, 155(7), 255–261.

  • Peyrot, M., Rubin, R. R., Lauritzen, T., et al.: Resistance to insulin therapyes among patients and providers. Results of the cross-national Diabetes Attitudes, Wishes and Needs (DAWN) study. Diabetes Care, 2005, 28, 2673–2679.

    Lauritzen T. , 'Resistance to insulin therapyes among patients and providers. Results of the cross-national Diabetes Attitudes, Wishes and Needs (DAWN) study ' (2005 ) 28 Diabetes Care : 2673 -2679.

    • Search Google Scholar
  • Geelhoed-Duijvestijn, P. H. L. M., Peyrot, M., Mathews, D. R., et al.: Physician resistance to prescribing insulin: An international study. Diabetologia, 2003, 46 (Suppl. 2), A274. (abstract)

    Mathews D. R. , 'Physician resistance to prescribing insulin: An international study ' (2003 ) 46 Diabetologia : A274 -.

    • Search Google Scholar
  • Brown, J. B., Nichols, G. A., Perry, A.: The burden of treatment failure in type 2 diabetes. Diabetes Care, 2004, 27, 1535–1540.

    Perry A. , 'The burden of treatment failure in type 2 diabetes ' (2004 ) 27 Diabetes Care : 1535 -1540.

    • Search Google Scholar
  • Hídvégi, T., Jermendy, Gy., Gerő, L., et al.: Metabolic control and mode of treatment in type 2 diabetic patients with oral antidiabetic drugs. [Anyagcserehelyzet és terápiás szokások 2-es típusú, oralis antidiabetikus kezelésben részesülő cukorbetegek körében.] Diabetol. Hung., 1999, 7, 253–259. [Hungarian]

    Gerő L. , 'Metabolic control and mode of treatment in type 2 diabetic patients with oral antidiabetic drugs. [Anyagcserehelyzet és terápiás szokások 2-es típusú, oralis antidiabetikus kezelésben részesülő cukorbetegek körében.] ' (1999 ) 7 Diabetol. Hung. : 253 -259.

    • Search Google Scholar
  • Inzucchi, S. E., Bergenstal, R. M., Buse, J. B., et al.: Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia, 2012, 55, 1577–1596.

    Buse J. B. , 'Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) ' (2012 ) 55 Diabetologia : 1577 -1596.

    • Search Google Scholar
  • Garber, A. J., Abrahamson, M. J., Barzilay, J. I., et al.: AACE comprehensive diabetes management algorhythm 2013. Endocr. Pract., 2013, 19, 327–336.

    Barzilay J. I. , 'AACE comprehensive diabetes management algorhythm 2013 ' (2013 ) 19 Endocr. Pract. : 327 -336.

    • Search Google Scholar
  • Gaál, Zs., Gerő, L., Hidvégi, T., et al.: Diagnosis of diabetes mellitus, therapy and care of diabetics in adulthood. In: Jermendy, Gy. (ed.): Recommendations of the Hungarian Diabetes Association, 2011. [A diabetes mellitus kórismézése, a cukorbetegek kezelése és gondozása felnőttkorban. In: Jermendy, Gy. (szerk.): A Magyar Diabetes Társaság szakmai irányelve, 2011.].; Diabetol. Hung., 2011, 19 (Suppl. 1), 5–72. [Hungarian]

    Hidvégi T. , 'Diagnosis of diabetes mellitus, therapy and care of diabetics in adulthood. [A diabetes mellitus kórismézése, a cukorbetegek kezelése és gondozása felnőttkorban.] ' (2011 ) 19 Diabetol. Hung. : 5 -72.

    • Search Google Scholar
  • Weng, J., Li, Y., Xu, W., et al.: Effect of intensive insulin therapy on beta-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trial. Lancet, 2008, 371, 1753–1760.

    Xu W. , 'Effect of intensive insulin therapy on beta-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trial ' (2008 ) 371 Lancet : 1753 -1760.

    • Search Google Scholar
  • Kramer, C. K., Zinman, B., Retnakaran, R.: Short-term intensive insulin therapy in type 2 diabetes mellitus: A systematic review and meta-analysis. Lancet Diabetes and Endocrinol., 2013, 1, 28–34.

    Retnakaran R. , 'Short-term intensive insulin therapy in type 2 diabetes mellitus: A systematic review and meta-analysis ' (2013 ) 1 Lancet Diabetes and Endocrinol. : 28 -34.

    • Search Google Scholar
  • Chon, S., Oh, S., Kim, S. W., et al.: The effect of early insulin therapy on pancreatic β-cell function and long-term glycemic control in newly diagnosed type 2 diabetic patients. Korean J. Intern. Med., 2010, 25, 273–281.

    Kim S. W. , 'The effect of early insulin therapy on pancreatic β-cell function and long-term glycemic control in newly diagnosed type 2 diabetic patients ' (2010 ) 25 Korean J. Intern. Med. : 273 -281.

    • Search Google Scholar
  • Chen, H. S., Wu, T. E., Jap, T. S., et al.: Beneficial effects of insulin on glycemic control and β-cell function in newly diagnosed type 2 diabetes with severe hyperglycemia after short-term intensive insulin therapy. Diabetes Care, 2008, 31, 1927–1932.

    Jap T. S. , 'Beneficial effects of insulin on glycemic control and β-cell function in newly diagnosed type 2 diabetes with severe hyperglycemia after short-term intensive insulin therapy ' (2008 ) 31 Diabetes Care : 1927 -1932.

    • Search Google Scholar
  • Xu, W., Weng, J.: Current role of short-term intensive insulin strategies in newly diagnosed type 2 diabetes. J. Diabetes, 2013, 5, 268–274.

    Weng J. , 'Current role of short-term intensive insulin strategies in newly diagnosed type 2 diabetes ' (2013 ) 5 J. Diabetes : 268 -274.

    • Search Google Scholar
  • Raz, I.: Guideline approach to therapy in patients with newly diagnosed type 2 diabetes. Diabetes Care, 2013, 36 (Suppl. 2), S139–S144.

    Raz I. , 'Guideline approach to therapy in patients with newly diagnosed type 2 diabetes ' (2013 ) 36 Diabetes Care : S139 -S144.

    • Search Google Scholar
  • Owens, D. R.: Clinial evidence for the earlier initiation of insulin therapy in type 2 diabetes. Diabetes Technol. Ther., 2013, 15, 776–785.

    Owens D. R. , 'Clinial evidence for the earlier initiation of insulin therapy in type 2 diabetes ' (2013 ) 15 Diabetes Technol. Ther. : 776 -785.

    • Search Google Scholar
  • Barkai, L., Hancu, N., Jermendy, Gy., et al.: Timely insulinisation in type 2 diabetes mellitus. Position statement of the Danube MCO experts. [Időben történő inzulinkezelés 2-es típusú diabetesben: a Duna MCO szakértőinek állásfoglalása.] Diabetol. Hung., 2012, 20, 285–289. [Hungarian]

    Jermendy Gy. , 'Timely insulinisation in type 2 diabetes mellitus. Position statement of the Danube MCO experts. [Időben történő inzulinkezelés 2-es típusú diabetesben: a Duna MCO szakértőinek állásfoglalása.] ' (2012 ) 20 Diabetol. Hung. : 285 -289.

    • Search Google Scholar
  • Niswender, K.: Early and aggressive initiation of insulin therapy for type 2 diabetes: what is the evidence? Clin. Diab., 2009, 27, 60–68.

    Niswender K. , 'Early and aggressive initiation of insulin therapy for type 2 diabetes: what is the evidence? ' (2009 ) 27 Clin. Diab. : 60 -68.

    • Search Google Scholar
  • Meneghini, L. F.: Early insulin treatment in type 2 diabetes. What are the pros? Diabetes Care, 2009, 32 (Suppl. 2), S266–S269.

    Meneghini L. F. , 'Early insulin treatment in type 2 diabetes. What are the pros? ' (2009 ) 32 Diabetes Care : S266 -S269.

    • Search Google Scholar
  • Retnakaran, R., Drucker, D. J.: Intensive insulin therapy in newly diagnosed type 2 diabetes. Lancet, 2008, 371, 1725–1726.

    Drucker D. J. , 'Intensive insulin therapy in newly diagnosed type 2 diabetes ' (2008 ) 371 Lancet : 1725 -1726.

    • Search Google Scholar
  • Kong, M. F.: Insulin should be prescribed at the outset of diagnosis of type 2 diabetes. For. Pract. Diab. Int., 2011, 28, 85–87.

    Kong M. F. , 'Insulin should be prescribed at the outset of diagnosis of type 2 diabetes ' (2011 ) 28 For. Pract. Diab. Int. : 85 -87.

    • Search Google Scholar
  • Bickerton, A.: Insulin should be prescribed at the ontset of diagnosis of type 2 diabetes. Against. Pract. Diab. Int., 2011, 28, 86–87/b.

    Bickerton A. , 'Insulin should be prescribed at the ontset of diagnosis of type 2 diabetes ' (2011 ) 28 Against. Pract. Diab. Int. : 86 -87/b.

    • Search Google Scholar
  • Davidson, M. B.: No need for the needle (at first). Diabetes Care, 2008, 31, 2070–2071.

    Davidson M. B. , 'No need for the needle (at first) ' (2008 ) 31 Diabetes Care : 2070 -2071.

  • Lebovitz, H. E.: Insulin: potential negative consequences of early routine use in patients with type 2 diabetes. Diabetes Care, 2011, 34 (Suppl. 2), S225–S230.

    Lebovitz H. E. , 'Insulin: potential negative consequences of early routine use in patients with type 2 diabetes ' (2011 ) 34 Diabetes Care : S225 -S230.

    • Search Google Scholar
  • Li, Y., Xu, W., Liao, Z., et al.: Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients is associated with improvement of β-cell function. Diabetes Care, 2004, 27, 2597–2602.

    Liao Z. , 'Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients is associated with improvement of β-cell function ' (2004 ) 27 Diabetes Care : 2597 -2602.

    • Search Google Scholar
  • The ORIGIN Trial Investigators: Basal insulin and cardiovascular and other outcomes in dysglycemia. N. Engl. J. Med., 2012, 367, 319–328.

    'Basal insulin and cardiovascular and other outcomes in dysglycemia ' (2012 ) 367 N. Engl. J. Med. : 319 -328.

    • Search Google Scholar
  • Nathan, D. M., Buse, J. B., Davidson, M. B., et al.: Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia, 2009, 52, 17–30.

    Davidson M. B. , 'Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes ' (2009 ) 52 Diabetologia : 17 -30.

    • Search Google Scholar
  • Yki-Järvinen, H., Esko, N., Eero, H., et al.: Clinical benefits and mechanisms of a sustained response to intermittent insulin therapy in type 2 diabetic patients with secondary drug failure. Am. J. Med., 1988, 84, 185–192.

    Eero H. , 'Clinical benefits and mechanisms of a sustained response to intermittent insulin therapy in type 2 diabetic patients with secondary drug failure ' (1988 ) 84 Am. J. Med. : 185 -192.

    • Search Google Scholar
  • Hasegawa, A., Iwasaka, H., Hagiwara, S., et al.: Anti-inflammatory effects of perioperative intensive insulin therapy during cardiac surgery with cardiopulmonary bypass. Surg. Today, 2011, 41, 1385–1390.

    Hagiwara S. , 'Anti-inflammatory effects of perioperative intensive insulin therapy during cardiac surgery with cardiopulmonary bypass ' (2011 ) 41 Surg. Today : 1385 -1390.

    • Search Google Scholar
  • Antoniades, C., Tousoulis, D., Marinou, K., et al.: Effects of insulin dependence on inflammatory process, thrombotic mechanisms and endothelial function, in patients with type 2 diabetes mellitus and coronary atherosclerosis. Clin. Cardiol., 2007, 30, 295–300.

    Marinou K. , 'Effects of insulin dependence on inflammatory process, thrombotic mechanisms and endothelial function, in patients with type 2 diabetes mellitus and coronary atherosclerosis ' (2007 ) 30 Clin. Cardiol. : 295 -300.

    • Search Google Scholar
  • Jansen, H. J., Stienstra, R., van Diepen, J. A., et al.: Start of insulin therapy in patients with type 2 diabetes mellitus promotes the influx of macrophages into subcutaneous adipose tissue. Diabetologia, 2013, 56, 2573–2581.

    Diepen J. A. , 'Start of insulin therapy in patients with type 2 diabetes mellitus promotes the influx of macrophages into subcutaneous adipose tissue ' (2013 ) 56 Diabetologia : 2573 -2581.

    • Search Google Scholar
  • Fonseca, V., Gill, J., Zhou, R., et al.: An analysis of early insulin glargine added to metformin with or without sulfonylurea: impact on glycaemic control and hypoglycaemia. Diabetes Obes. Metab., 2011, 13, 814–822.

    Zhou R. , 'An analysis of early insulin glargine added to metformin with or without sulfonylurea: impact on glycaemic control and hypoglycaemia ' (2011 ) 13 Diabetes Obes. Metab. : 814 -822.

    • Search Google Scholar
  • Riddle, M. C., Vlajnic, A., Zhou, R., et al.: Baseline HbA1c predicts attainment of 7.0% HbA1c target with structured titration of insulin glargine in type 2 diabetes: a patient-level analysis of 12 studies. Diabetes Obes. Metab., 2013, 15, 819–825.

    Zhou R. , 'Baseline HbA1c predicts attainment of 7.0% HbA1c target with structured titration of insulin glargine in type 2 diabetes: a patient-level analysis of 12 studies ' (2013 ) 15 Diabetes Obes. Metab. : 819 -825.

    • Search Google Scholar
  • Aschner, P., Chan, J., Owens, D. R., et al.: Insulin glargine versus sitagliptin in insulin-naive patients with type 2 diabetes mellitus uncontrolled on metformin (EASIE): a multicentre, randomised open-label trial. Lancet, 2012, 379, 2262–2269.

    Owens D. R. , 'Insulin glargine versus sitagliptin in insulin-naive patients with type 2 diabetes mellitus uncontrolled on metformin (EASIE): a multicentre, randomised open-label trial ' (2012 ) 379 Lancet : 2262 -2269.

    • Search Google Scholar
  • Hollander, P., Raslova, K., Skjøth, T. V., et al.: Efficacy and safety of insulin detemir once daily in combination with sitagliptin and metformin: the TRANSITION randomized controlled trial. Diabetes Obes. Metab., 2011, 13, 268–275.

    Skjøth T. V. , 'Efficacy and safety of insulin detemir once daily in combination with sitagliptin and metformin: the TRANSITION randomized controlled trial ' (2011 ) 13 Diabetes Obes. Metab. : 268 -275.

    • Search Google Scholar
  • Ceriello, A., Ihnat, M. A., Thorpe, J. E.: The “metabolic memory” is more than just tight glucose control necessary to prevent diabetic complications? J. Clin.; Eendocrinol. Metab., 2009, 94, 410–415.

    Thorpe J. E. , 'The “metabolic memory” is more than just tight glucose control necessary to prevent diabetic complications? ' (2009 ) 94 J. Clin.; Eendocrinol. Metab. : 410 -415.

    • Search Google Scholar
  • Winkler, G. and partecipants of the HA-BOT study: Basal insulin (detemir) supplemented oral antidiabetic therapy. Results of the first large Hungarian observational study (HA-BOT). [Bázisinzulinnal (detemir) kiegészített orális antidiabetikus kezelés. Az első nagy esetszámú magyar obszervációs vizsgálat (HA-BOT) tapasztalatai.] Diabetol. Hung., 2011, 19, 135–142. [Hungarian]

    Winkler G. , 'Basal insulin (detemir) supplemented oral antidiabetic therapy. Results of the first large Hungarian observational study (HA-BOT). [Bázisinzulinnal (detemir) kiegészített orális antidiabetikus kezelés. Az első nagy esetszámú magyar obszervációs vizsgálat (HA-BOT) tapasztalatai.] ' (2011 ) 19 Diabetol. Hung. : 135 -142.

    • Search Google Scholar
  • Gyimesi, A., Winkler, G.: The LANDSCAPE-HU study: change to basal-bolus analogue insulin regime with glulisin insulin in the everydays practice. [LANDSCAPE-HU vizsgálat: glulisinnel kiegészített analóg bázis-bólus rezsimre történő váltás hatékony a mindennapi gyakorlatban.] Metabolizmus, 2009, 7, 43–45. [Hungarian]

    Winkler G. , 'The LANDSCAPE-HU study: change to basal-bolus analogue insulin regime with glulisin insulin in the everydays practice. [LANDSCAPE-HU vizsgálat: glulisinnel kiegészített analóg bázis-bólus rezsimre történő váltás hatékony a mindennapi gyakorlatban.] ' (2009 ) 7 Metabolizmus : 43 -45.

    • Search Google Scholar
  • Lingvay, I., Legendre, J. L., Kaloyanova, P. F., et al.: Insulin-based versus triple oral therapy for newly diagnosed type 2 diabetes. Which is better? Diabetes Care, 2009, 32, 1789–1795.

    Kaloyanova P. F. , 'Insulin-based versus triple oral therapy for newly diagnosed type 2 diabetes. Which is better? ' (2009 ) 32 Diabetes Care : 1789 -1795.

    • Search Google Scholar
  • Harrison, L. B., Adams-Huet, B., Raskin, P., et al.: β-cell function preservation after 3.5 years of intensive diabetes therapy. Diabetes Care, 2012, 35, 1406–1412.

    Raskin P. , 'β-cell function preservation after 3.5 years of intensive diabetes therapy ' (2012 ) 35 Diabetes Care : 1406 -1412.

    • Search Google Scholar
  • Perfetti, R.: Combining basal insulin analogs with glukagon-like peptide-1 mimetics. Diabetes Technol. Ther., 2011, 13, 873–881.

    Perfetti R. , 'Combining basal insulin analogs with glukagon-like peptide-1 mimetics ' (2011 ) 13 Diabetes Technol. Ther. : 873 -881.

    • Search Google Scholar
  • Cernea, S., Raz, I.: Therapy in the early stage: incretins. Diabetes Care, 2011, 34 (Suppl. 2), S264–S271.

    Raz I. , 'Therapy in the early stage: incretins ' (2011 ) 34 Diabetes Care : S264 -S271.

All Time Past Year Past 30 Days
Abstract Views 41 41 1
Full Text Views 10 2 0
PDF Downloads 4 1 0